Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture
Cytotechnology · 2025-02 · 77 (1)
DOI: 10.1007/s10616-024-00669-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cytotechnology, online erschienen am 18.11.2024. Verfasst von Hisashi Saeki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Culture Media Technical Department, FUJIFILM Wako Pure Chemical Corp., 3-17-35 Niizo-Minami, Toda-Shi, Saitama 335-0026 Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Chinese hamster ovary (CHO) cell lines, derived as subclones from the original CHO cell line, are widely used hosts for current biopharmaceutical productions. Recently, a highly proliferative host cell line, CHO-MK, was established from the Chinese hamster ovary tissue. In this study, we assessed the fundamental culture characteristics and capabilities of CHO-MK cells for monoclonal antibody (mAb) production using specified chemically defined media. To achieve this, we established fed-batch cultures of model CHO-MK cells in shake flasks and ambr15 and 2 L bioreactors under various conditions. The mAb-producing CHO-MK cell line A produced 12.6 g/L of antibody within 7 days in the fed-batch culture using a 2 L bioreactor, with a seeding density of 1 × 106 cells/mL. This performance corresponded to a space-time yield of 1.80 g/L/day, representing a productivity level that could be challengingly attained in fed-batch cultures using conventional CHO cells. In addition, when we subjected six different mAb-producing CHO-MK cell lines to fed-batch culture in the ambr15 bioreactor for 7 days, the antibody production ranged between 5.1 and 10.8 g/L, confirming that combining CHO-MK cells and specified media leads to enhanced versatility. These discoveries underscore that CHO-MK cells combined with specified media might represent a next-generation production platform, which could potentially respond to an increasing demand for antibody drugs, reducing production costs, and shortening antibody drug development times. This study is expected to serve as a benchmark for future production process development using CHO-MK cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Culture Media Technical Department, FUJIFILM Wako Pure Chemical Corp., 3-17-35 Niizo-Minami, Toda-Shi, Saitama 335-0026 Japan.
Zitieren
APA
Saeki, H., Fueki, K., & Maeda, N. (2025). Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture. Cytotechnology, 77(1). https://doi.org/10.1007/s10616-024-00669-4
Vancouver
Saeki H, Fueki K, Maeda N. Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture. Cytotechnology. 2025;77(1). doi:10.1007/s10616-024-00669-4
BibTeX
@article{Saeki2025,
author = {Saeki, Hisashi and Fueki, Kaori and Maeda, Naoki},
title = {Enhancing monoclonal antibody production efficiency using CHO-MK cells and specific media in a conventional fed-batch culture},
journal = {Cytotechnology},
year = {2025},
volume = {77},
number = {1},
doi = {10.1007/s10616-024-00669-4}
}
EUVIMED